1. Home
  2. BGSF vs ASRT Comparison

BGSF vs ASRT Comparison

Compare BGSF & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BGSF Inc.

BGSF

BGSF Inc.

HOLD

Current Price

$5.99

Market Cap

63.4M

ML Signal

HOLD

Logo Assertio Holdings Inc.

ASRT

Assertio Holdings Inc.

HOLD

Current Price

$12.18

Market Cap

76.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGSF
ASRT
Founded
2007
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.4M
76.0M
IPO Year
2013
2004

Fundamental Metrics

Financial Performance
Metric
BGSF
ASRT
Price
$5.99
$12.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$9.00
$35.00
AVG Volume (30 Days)
19.9K
33.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
33.45%
N/A
EPS Growth
67.37
95.07
EPS
N/A
N/A
Revenue
$272,499,000.00
$124,961,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.14
$1.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.91
$0.51
52 Week High
$8.20
$12.95

Technical Indicators

Market Signals
Indicator
BGSF
ASRT
Relative Strength Index (RSI) 56.96 61.08
Support Level $5.93 $0.67
Resistance Level $6.38 $12.75
Average True Range (ATR) 0.25 0.52
MACD -0.03 -0.18
Stochastic Oscillator 47.20 78.31

Price Performance

Historical Comparison
BGSF
ASRT

About BGSF BGSF Inc.

BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. two segments: Property Management and Professional. In the Property Management segment is a provider of office and maintenance talent. The Professional segment provides IT professionals with expertise in SAP, Workday, Peoplesoft, Hyperion, Oracle, One Stream, cyber, project management, managed services, and other IT workforce solutions to client partners on a national basis. The group generates the majority of its revenue from the Professional segment.

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: